Novel urine test to diagnose cancer developed Isra Zaman15 Feb 2023 9:15 AM ISTIn a recent study researchers tried to find metabolites in urine. They succeeded in developing a strip-type urine sensor that can amplify the light...
Declining PSA levels after enzalutamide treatment predict longer survival in high risk prostate cancer patients Dr. Kamal Kant Kohli12 Feb 2023 8:00 PM ISTResearchers have found in a new study that falling PSA levels predict longer survival in prostate cancer patients at high risk of metastases.Declines...
Medical Bulletin 9/February/2023 Isra Zaman9 Feb 2023 3:42 PM ISTHere are the top medical news for the day:Novel blood test to identify prostate cancer with 94 percent accuracyNew research shows that the Prostate...
Novel blood test to identify prostate cancer with 94 percent accuracy Isra Zaman9 Feb 2023 9:00 AM ISTNew research shows that the Prostate Screening EpiSwitch (PSE) blood test is 94 per cent accurate-beating the currently used prostate-specific antigen...
Plant-based diets may be associated with lower risk of aggressive prostate cancer Dr. Shravani Dali2 Feb 2023 9:45 AM ISTPlant-based diets may be associated with a lower risk of aggressive prostate cancer suggests a recent study published in The American Journal of...
ADT increases risk of diabetes and hypertension in Prostate cancer patients but not metabolic syndrome Aditi30 Jan 2023 8:00 PM ISTUnited States: An original study published in Clinical Genitourinary cancer has concluded that in Prostate Cancer (PC) patients, Androgen Deprivation...
Medical Bulletin 25/January/2023 Isra Zaman25 Jan 2023 2:45 PM ISTHere are the top medical news for the day:Poor sleep during teenage years may increase subsequent MS risk: Study Insufficient and disturbed sleep...
Neuronal molecule that make prostate cancer more aggressive identified in recent study Isra Zaman25 Jan 2023 9:45 AM ISTProstate cancer is the second most common cancer and the second leading cause of cancer death among American men. Now, researchers have discovered key...
Novartis gets European Commission nod for Pluvicto to treat progressive PSMA-positive metastatic castration-resistant prostate cancer Ruchika Sharma17 Jan 2023 3:30 PM ISTPluvicto is an intravenous radioligand therapy combining a targeting compound (a ligand) with a therapeutic radionuclide (a radioactive particle, in...
MRI-guided radiotherapy found beneficial for patients with localized prostate cancer Isra Zaman14 Jan 2023 9:30 AM ISTResults from the first randomized phase III clinical trial to directly compare MRI-guided stereotactic body radiotherapy (SBRT) with the same therapy...
Prostate cancer recurrence can be accurately detected by PSMA PET/MRI Dr. Kamal Kant Kohli8 Jan 2023 8:00 PM ISTUSA: PSMA (prostate-specific membrane antigen) PET/MRI can successfully determine whether the cancer is likely to return within two years of...
Zydus Gets CDSCO panel Nod for BE Study Of Antineoplastic Drug Relugolix Dr. Divya Colin2 Jan 2023 5:30 PM ISTNew Delhi: In response to the drug major Zydus proposal for manufacture and market of anticancer drug Relugolix Tablets 120mg along with...
